By Sabrina Johnson
When the WHO declared COVID-19 a pandemic, the world shut down. It was an unforgettable time in history: countries sealing borders, businesses closing, and governments issuing stay-at-home orders. Biotech and pharmaceutical companies around the globe fought to keep their clinical trials on track. But with altered clinic procedures, packed hospitals, masking, social distancing, and constantly evolving guidelines, we all felt the impact across clinical site engagement, study design, and patient enrollment. Effectively engaging with a CRO assisting with study execution had never been more important than in that moment — and during the two years that have passed since the WHO’s initial declaration of the pandemic.